Concentrix Corp has a consensus price target of $73.5, established from looking at the 16 latest analyst ratings. The last 3 analyst ratings were released from Canaccord Genuity, Barrington Research, and Scotiabank on June 27, 2024, June 21, 2024, and April 29, 2024. With an average price target of $98 between Canaccord Genuity, Barrington Research, and Scotiabank, there's an implied 47.84% upside for Concentrix Corp from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/27/2024 | Buy Now | 88.57% | Canaccord Genuity | Joseph Vafi | $125 → $125 | Maintains | Buy | Get Alert |
06/21/2024 | Buy Now | 26.72% | Barrington Research | Vincent Colicchio | $84 → $84 | Maintains | Outperform | Get Alert |
04/29/2024 | Buy Now | 28.22% | Scotiabank | Divya Goyal | $120 → $85 | Maintains | Sector Outperform | Get Alert |
03/27/2024 | Buy Now | — | B of A Securities | Ruplu Bhattacharya | — | Downgrade | Neutral → Underperform | Get Alert |
03/27/2024 | Buy Now | 26.72% | Barrington Research | Vincent Colicchio | $121 → $84 | Maintains | Outperform | Get Alert |
03/20/2024 | Buy Now | 82.53% | Barrington Research | Vincent Colicchio | $121 → $121 | Maintains | Outperform | Get Alert |
01/25/2024 | Buy Now | 82.53% | Barrington Research | Vincent Colicchio | $98 → $121 | Maintains | Outperform | Get Alert |
08/24/2023 | Buy Now | 81.02% | Scotiabank | Divya Goyal | → $120 | Initiates | → Sector Outperform | Get Alert |
06/29/2023 | Buy Now | 43.31% | B of A Securities | Ruplu Bhattacharya | — | Downgrade | Buy → Neutral | Get Alert |
06/29/2023 | Buy Now | 47.84% | Barrington Research | Vincent Colicchio | $165 → $98 | Maintains | Outperform | Get Alert |
06/26/2023 | Buy Now | 148.91% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | Outperform → Outperform | Get Alert |
04/12/2023 | Buy Now | 126.28% | Canaccord Genuity | Joseph Vafi | → $150 | Initiates | → Buy | Get Alert |
03/30/2023 | Buy Now | 148.91% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | → Outperform | Get Alert |
03/27/2023 | Buy Now | 148.91% | Barrington Research | Vincent Colicchio | → $165 | Reiterates | → Outperform | Get Alert |
09/30/2022 | Buy Now | 162.48% | Barrington Research | Vincent Colicchio | $183 → $174 | Maintains | Outperform | Get Alert |
07/05/2022 | Buy Now | 176.06% | Barrington Research | Vincent Colicchio | $202 → $183 | Maintains | Outperform | Get Alert |
The latest price target for Concentrix (NASDAQ:CNXC) was reported by Canaccord Genuity on June 27, 2024. The analyst firm set a price target for $125.00 expecting CNXC to rise to within 12 months (a possible 88.57% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Concentrix (NASDAQ:CNXC) was provided by Canaccord Genuity, and Concentrix maintained their buy rating.
There is no last upgrade for Concentrix
The last downgrade for Concentrix Corp happened on March 27, 2024 when B of A Securities changed their price target from N/A to N/A for Concentrix Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Concentrix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Concentrix was filed on June 27, 2024 so you should expect the next rating to be made available sometime around June 27, 2025.
While ratings are subjective and will change, the latest Concentrix (CNXC) rating was a maintained with a price target of $125.00 to $125.00. The current price Concentrix (CNXC) is trading at is $66.29, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.